Literature DB >> 27421248

Significance of platelet distribution width as a severity marker of erectile dysfunction.

L Q Guo1, Y Q Liu1, W D Sun1, M Z Yuan1,2, Z Y Xiao2, H B Song1,2, S T Zhao2, X L Zhang2, N Ge1.   

Abstract

Mean platelet volume (MPV) and Platelet distribution width (PDW) are potential markers in platelet activation. In present study, we aimed to evaluate MPV and PDW as potential severity markers for those patients who are complaining erectile dysfunction (ED). A total of 358 participants were enrolled in this study. The whole cohort was asked to complete the International Index of Erectile Function-5 (IIEF-5) questionnaire. The participants were classified into 3 groups: control group (n = 120), mild ED (n = 118) and severe ED (n = 120). We found in our cohort MPV and PDW were significantly higher in both mild ED group and severe ED group than control group (9.24 ± 0.70 and 9.71 ± 0.80 versus 8.56 ± 0.62 for MPV; 14.48 ± 1.29 and 14.98 ± 1.60 versus 12.86 ± 1.13 for PDW respectively). The MPV and PDW increased as the disease progressed. In the mild and severe ED groups, a significant inverse correlation was detected between the mean values of IIEF-5 score and PDW. Furthermore, in the receiver operating characteristic curve analysis, the area under the curve of the MPV and PDW to predict severe ED was 0.818 and 0.848 respectively. Our study establishes a dose-dependent association between the PDW and ED. Therefore, the PDW can serve as a potential marker for predicting the severity of ED.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  erectile dysfunction; platelet distribution width; severity

Mesh:

Year:  2016        PMID: 27421248     DOI: 10.1111/and.12628

Source DB:  PubMed          Journal:  Andrologia        ISSN: 0303-4569            Impact factor:   2.775


  4 in total

1.  Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with vascular erectile dysfunction: a comparative randomized prospective study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2019-06-22       Impact factor: 2.370

2.  Antiplatelet (aspirin) therapy as a new option in the treatment of vasculogenic erectile dysfunction: a prospective randomized double-blind placebo-controlled study.

Authors:  Zeki Bayraktar; Selami Albayrak
Journal:  Int Urol Nephrol       Date:  2018-01-17       Impact factor: 2.370

3.  Significance of hyperhomocysteinaemia as an effective marker for vasculogenic erectile dysfunction: a cross-sectional study.

Authors:  Limin Liao; Mingzhen Yuan; Xuesheng Wang; Fan Zhang; Liqiang Guo; Zhen Ma
Journal:  Transl Androl Urol       Date:  2022-03

4.  A Novel Method to Quantify Penile Arterial Blood Supply Using Shear Wave Elastography During Penile Duplex Ultrasound in Men with Erectile Dysfunction.

Authors:  Jingshu Zhang; Wang Zhou; Yuyang Zhang; Wei Zhang; Chaoxue Zhang
Journal:  Med Sci Monit       Date:  2022-03-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.